The symposium programme will consist of an opening session, plenary sessions, technical sessions, poster and interactive content sessions, exhibitions, and a closing session.
The opening session will include welcoming addresses by representatives of the IAEA, cooperating organizations, and other relevant organizations.
The plenary sessions will continue with a combination of invited keynote presentations and submitted papers addressing the main themes and topics of the symposium.
Each technical session will include presentations and/or panel discussions delivered by participants which will have been selected based on the abstracts submitted.
The symposium will also include poster sessions, and sufficient time will be provided for discussion and interaction with colleagues.
The final plenary session on the last day of the symposium will be dedicated to conclusions and recommendations on the way forward.
The scope of the conference covers, but is not limited to, the following topical areas:
-
Production of PET- and SPECT-based diagnostic, therapeutic and theranostic medical radioisotopes-1
PRI -
Production of radionuclide generators
PRG -
Production of PET- and SPECT-based diagnostic, therapeutic, and theranostic radiopharmaceuticals
PRP -
Quality control and quality assurance of medical radioisotopes and radiopharmaceuticals
QCA -
Pre-clinical evaluation of radiopharmaceuticals
PCE -
Design of industrial, hospital and centralized radiopharmacy facilities
DRF -
Health regulatory aspects related to the production of radiopharmaceuticals
HRA -
Education, including e-learning, certification and training methodologies for professionals involved in radiopharmacy
EDU -
Nanosized radiopharmaceuticals
Nanosized radiopharmaceuticals
